IQVIA BIOTECH LTD.
Company Information
- Company Number
- 03299057
- Registered Address
- 3 Forbury Place, 23 Forbury Road, Reading, United Kingdom, RG1 3JH
- Status
- Active
- Employee Count
- 170
- Turnover
- £86,033,000
- EBITDA
- £20,687,000
Additional Details
- Website
- https://novellaclinical.com/
- Company Type
- Private limited Company
- Incorporated On
- 6 January 1997
- Nature of Business
- 72110 - Research and experimental development on biotechnology
- Industries
- Life Sciences And Medical Technology
- Region
- South East
Time to Pay
Payment Timeline
Payment Features
Payment Score History
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jan 2025 - 30 Jun 2025 | 23 Jul 2025 | 42 | 63% | 13% | 24% | 26% |
| 01 Jul 2024 - 31 Dec 2024 | 21 Jan 2025 | 42 | 46% | 17% | 37% | 66% |
| 01 Jul 2023 - 31 Dec 2023 | 23 Jan 2024 | 20 | 77% | 14% | 9% | 55% |
| 01 Jan 2023 - 30 Jun 2023 | 25 Jul 2023 | 18 | 82% | 10% | 8% | 41% |
| 01 Jul 2022 - 31 Dec 2022 | 23 Jan 2023 | 16 | 84% | 10% | 6% | 26% |
| 01 Jan 2022 - 30 Jun 2022 | 21 Jul 2022 | 20 | 81% | 9% | 10% | 30% |
| 01 Jul 2021 - 31 Dec 2021 | 21 Jan 2022 | 18 | 81% | 8% | 11% | 34% |
| 01 Jan 2021 - 30 Jun 2021 | 26 Jul 2021 | 23 | 80% | 6% | 14% | 43% |
Payment Time Trends
Payment Distribution Trends
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
90 days payment from date of invoice
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
90
Dispute Resolution Process
The main point of contact for disputes is the Global Shared Services Centre(locations in Slovakia and India) . When an invoice is rejected an email is sent indicating the invoice number and reason for rejection. To resolve a dispute, the supplier is required to provide any missing information or a corrected invoice. IQVIA follows a strict no PO no pay policy. The PO number is communicated by IQVIA's procurement team at the time of placing the order.
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Company Summary
IQVIA Biotech Ltd. is a global biotechnology company that offers innovative products and services in the healthcare industry. The company is committed to sustainability and has various programs in place to promote ethical and responsible business practices.
Their sustainability program includes initiatives such as reducing carbon emissions, promoting diversity and inclusion, and investing in community engagement and development. They also prioritize ethical sourcing of materials and strive to minimize their environmental impact.
IQVIA Biotech Ltd. offers a range of products and services, including clinical trial management, data analytics, and regulatory consulting. Their products and services are designed to improve the efficiency and effectiveness of clinical trials, ultimately leading to better patient outcomes.
The key people at IQVIA Biotech Ltd. include CEO Ari Bousbib, who has extensive experience in the healthcare industry, and Chief Sustainability Officer Talia Kauffman, who leads the company's sustainability efforts.
For more information about IQVIA Biotech Ltd. and their products and services, visit their website at https://www.iqviabiotech.com/. The company's registered office address is 210 Pentonville Road, London, N1 9JY, United Kingdom.
